Patent details

300305 Product Name: Aliskiren of een farmaceutisch aanvaardbaar zout hiervan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300305
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1303478
Status:
Lapsed by non payment annual fee (art. 62 ROW and art 14(c) of the EC Regulations
Application number:
300305
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/07/408/001-020
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/08/2007
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
13/11/2007
First Marketing Authorization date:
22/08/2007
Grant date:
05/12/2007
Activation date:
26/06/2021
Lapsed By Non Payment Annual Fee Date:
01/07/2021
Renunciation Date:
NullificationDate:
Registration date:
13/11/2007
SPC/SPC Extension Expiration Date:
21/08/2022
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
19/11/2019
 
 

 

Name:
Noden Pharma DAC
Address:
D'Olier Chambers 16A D'Olier Street, Dublin 2, Ireland (IE)

Historical Applicant/holder

From:
19/11/2019
To:
19/11/2019

 

Name:
Noden Pharma DAC
Address:
D'Olier Chambers 16A D'Olier Street, Dublin 2, Ireland (IE)

From:
09/03/2018
To:
15/05/2018

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
13/11/2007
To:
09/03/2018

 

Name:
Speedel Pharma AG
Address:
Im Hirschgässlein 11, 4051, Basel, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
13/11/2007
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
05/22
Publication date:
02/02/2022
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
26/21
Publication date:
30/06/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
CO
Journal edition number:
27/18
Publication date:
27/06/2018
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
CO
Journal edition number:
21/18
Publication date:
16/05/2018
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
SPC
Journal edition number:
2008/02
Publication date:
01/02/2008
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

6

Bulletin Heading:
SPC
Journal edition number:
2008/01
Publication date:
02/01/2008
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC201902341A
Date Registered:
19/11/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201800928A
Date Registered:
15/05/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Noden Pharma DAC
Address:
56 Fitzwilliam Square, Dublin 2 , Ireland (IE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201800503A
Date Registered:
09/03/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
05/12/2007 SPC Documents Certificate SPC 1 PDF /5/0/3/0/0/0400300305/docs/300305_1_supplprotectioncertificate20200901125204737.pdf
05/12/2007 Outgoing Correspondence Outgoing Letter 1 PDF /5/0/3/0/0/0400300305/docs/300305_3_outgoingcorrespondence20071205.pdf
14/11/2007 Outgoing Correspondence Outgoing Letter 1 PDF /5/0/3/0/0/0400300305/docs/300305_2_outgoingcorrespondence20071114.pdf
13/11/2007 SPC Documents Summary of the characteristics of the product 17 PDF /5/0/3/0/0/0400300305/docs/300305_0_supplprotectioncertificate20200901105013395.pdf
13/11/2007 Application Form First filed application form 2 PDF /5/0/3/0/0/0400300305/docs/300305_4_applicationform20071113.pdf